![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NDUFV3 |
Gene summary for NDUFV3 |
![]() |
Gene information | Species | Human | Gene symbol | NDUFV3 | Gene ID | 4731 |
Gene name | NADH:ubiquinone oxidoreductase subunit V3 | |
Gene Alias | CI-10k | |
Cytomap | 21q22.3 | |
Gene Type | protein-coding | GO ID | GO:0006091 | UniProtAcc | P56181 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4731 | NDUFV3 | GSM4909293 | Human | Breast | IDC | 1.96e-14 | 4.57e-01 | 0.1581 |
4731 | NDUFV3 | GSM4909294 | Human | Breast | IDC | 3.57e-02 | 2.26e-01 | 0.2022 |
4731 | NDUFV3 | GSM4909296 | Human | Breast | IDC | 4.99e-03 | 8.85e-04 | 0.1524 |
4731 | NDUFV3 | GSM4909297 | Human | Breast | IDC | 1.41e-03 | -9.63e-02 | 0.1517 |
4731 | NDUFV3 | GSM4909301 | Human | Breast | IDC | 4.08e-02 | -1.42e-01 | 0.1577 |
4731 | NDUFV3 | GSM4909304 | Human | Breast | IDC | 1.28e-07 | 3.90e-01 | 0.1636 |
4731 | NDUFV3 | GSM4909308 | Human | Breast | IDC | 2.62e-03 | 2.55e-01 | 0.158 |
4731 | NDUFV3 | GSM4909311 | Human | Breast | IDC | 1.17e-22 | 9.21e-02 | 0.1534 |
4731 | NDUFV3 | GSM4909312 | Human | Breast | IDC | 2.16e-08 | 1.97e-01 | 0.1552 |
4731 | NDUFV3 | GSM4909315 | Human | Breast | IDC | 1.14e-16 | 6.31e-01 | 0.21 |
4731 | NDUFV3 | GSM4909316 | Human | Breast | IDC | 3.72e-13 | 6.57e-01 | 0.21 |
4731 | NDUFV3 | GSM4909317 | Human | Breast | IDC | 1.94e-02 | 2.37e-01 | 0.1355 |
4731 | NDUFV3 | GSM4909319 | Human | Breast | IDC | 1.74e-18 | -1.87e-01 | 0.1563 |
4731 | NDUFV3 | GSM4909320 | Human | Breast | IDC | 7.37e-04 | 7.86e-02 | 0.1575 |
4731 | NDUFV3 | GSM4909321 | Human | Breast | IDC | 2.84e-11 | 6.84e-03 | 0.1559 |
4731 | NDUFV3 | brca2 | Human | Breast | Precancer | 1.47e-05 | 2.40e-01 | -0.024 |
4731 | NDUFV3 | NCCBC14 | Human | Breast | DCIS | 1.22e-02 | 1.25e-01 | 0.2021 |
4731 | NDUFV3 | NCCBC5 | Human | Breast | DCIS | 5.39e-08 | 1.37e-01 | 0.2046 |
4731 | NDUFV3 | P1 | Human | Breast | IDC | 2.92e-08 | 7.33e-02 | 0.1527 |
4731 | NDUFV3 | DCIS2 | Human | Breast | DCIS | 2.23e-41 | 3.86e-02 | 0.0085 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Stomach | WIM | ![]() |
Stomach | SIM | ![]() |
Liver | NAFLD | ![]() |
Liver | Cirrhotic | ![]() |
Liver | HCC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00460349 | Breast | Precancer | ATP metabolic process | 82/1080 | 277/18723 | 1.94e-36 | 5.19e-33 | 82 |
GO:00061199 | Breast | Precancer | oxidative phosphorylation | 53/1080 | 141/18723 | 1.15e-29 | 2.04e-26 | 53 |
GO:00090608 | Breast | Precancer | aerobic respiration | 58/1080 | 189/18723 | 5.69e-27 | 7.62e-24 | 58 |
GO:00060918 | Breast | Precancer | generation of precursor metabolites and energy | 94/1080 | 490/18723 | 1.54e-25 | 1.64e-22 | 94 |
GO:00453338 | Breast | Precancer | cellular respiration | 59/1080 | 230/18723 | 5.97e-23 | 5.32e-20 | 59 |
GO:00159808 | Breast | Precancer | energy derivation by oxidation of organic compounds | 70/1080 | 318/18723 | 8.33e-23 | 6.37e-20 | 70 |
GO:00196468 | Breast | Precancer | aerobic electron transport chain | 34/1080 | 87/18723 | 3.95e-20 | 2.64e-17 | 34 |
GO:00427738 | Breast | Precancer | ATP synthesis coupled electron transport | 35/1080 | 95/18723 | 1.08e-19 | 5.76e-17 | 35 |
GO:00427758 | Breast | Precancer | mitochondrial ATP synthesis coupled electron transport | 35/1080 | 95/18723 | 1.08e-19 | 5.76e-17 | 35 |
GO:00229048 | Breast | Precancer | respiratory electron transport chain | 35/1080 | 114/18723 | 8.51e-17 | 3.26e-14 | 35 |
GO:00229008 | Breast | Precancer | electron transport chain | 42/1080 | 175/18723 | 1.37e-15 | 4.59e-13 | 42 |
GO:00061208 | Breast | Precancer | mitochondrial electron transport, NADH to ubiquinone | 19/1080 | 51/18723 | 2.05e-11 | 2.49e-09 | 19 |
GO:004603414 | Breast | IDC | ATP metabolic process | 85/1434 | 277/18723 | 6.42e-30 | 1.82e-26 | 85 |
GO:000611913 | Breast | IDC | oxidative phosphorylation | 56/1434 | 141/18723 | 1.87e-26 | 3.53e-23 | 56 |
GO:000906013 | Breast | IDC | aerobic respiration | 61/1434 | 189/18723 | 4.42e-23 | 6.27e-20 | 61 |
GO:000609113 | Breast | IDC | generation of precursor metabolites and energy | 103/1434 | 490/18723 | 1.53e-21 | 1.74e-18 | 103 |
GO:004533313 | Breast | IDC | cellular respiration | 62/1434 | 230/18723 | 5.98e-19 | 4.25e-16 | 62 |
GO:004277313 | Breast | IDC | ATP synthesis coupled electron transport | 38/1434 | 95/18723 | 1.65e-18 | 9.36e-16 | 38 |
GO:004277513 | Breast | IDC | mitochondrial ATP synthesis coupled electron transport | 38/1434 | 95/18723 | 1.65e-18 | 9.36e-16 | 38 |
GO:001964613 | Breast | IDC | aerobic electron transport chain | 36/1434 | 87/18723 | 3.48e-18 | 1.80e-15 | 36 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501218 | Breast | Precancer | Parkinson disease | 99/684 | 266/8465 | 3.58e-42 | 5.65e-40 | 4.33e-40 | 99 |
hsa0502016 | Breast | Precancer | Prion disease | 95/684 | 273/8465 | 1.39e-37 | 1.46e-35 | 1.12e-35 | 95 |
hsa0501616 | Breast | Precancer | Huntington disease | 98/684 | 306/8465 | 2.85e-35 | 2.25e-33 | 1.72e-33 | 98 |
hsa0019016 | Breast | Precancer | Oxidative phosphorylation | 59/684 | 134/8465 | 6.15e-30 | 3.24e-28 | 2.48e-28 | 59 |
hsa0501016 | Breast | Precancer | Alzheimer disease | 103/684 | 384/8465 | 1.03e-29 | 4.66e-28 | 3.57e-28 | 103 |
hsa0501416 | Breast | Precancer | Amyotrophic lateral sclerosis | 98/684 | 364/8465 | 2.13e-28 | 8.41e-27 | 6.44e-27 | 98 |
hsa0502216 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0520818 | Breast | Precancer | Chemical carcinogenesis - reactive oxygen species | 68/684 | 223/8465 | 3.61e-23 | 1.14e-21 | 8.73e-22 | 68 |
hsa0471418 | Breast | Precancer | Thermogenesis | 68/684 | 232/8465 | 4.40e-22 | 1.26e-20 | 9.69e-21 | 68 |
hsa0541518 | Breast | Precancer | Diabetic cardiomyopathy | 63/684 | 203/8465 | 5.63e-22 | 1.48e-20 | 1.14e-20 | 63 |
hsa0493216 | Breast | Precancer | Non-alcoholic fatty liver disease | 48/684 | 155/8465 | 6.16e-17 | 1.50e-15 | 1.15e-15 | 48 |
hsa0472316 | Breast | Precancer | Retrograde endocannabinoid signaling | 25/684 | 148/8465 | 3.05e-04 | 2.47e-03 | 1.89e-03 | 25 |
hsa0501219 | Breast | Precancer | Parkinson disease | 99/684 | 266/8465 | 3.58e-42 | 5.65e-40 | 4.33e-40 | 99 |
hsa0502017 | Breast | Precancer | Prion disease | 95/684 | 273/8465 | 1.39e-37 | 1.46e-35 | 1.12e-35 | 95 |
hsa0501617 | Breast | Precancer | Huntington disease | 98/684 | 306/8465 | 2.85e-35 | 2.25e-33 | 1.72e-33 | 98 |
hsa0019017 | Breast | Precancer | Oxidative phosphorylation | 59/684 | 134/8465 | 6.15e-30 | 3.24e-28 | 2.48e-28 | 59 |
hsa0501017 | Breast | Precancer | Alzheimer disease | 103/684 | 384/8465 | 1.03e-29 | 4.66e-28 | 3.57e-28 | 103 |
hsa0501417 | Breast | Precancer | Amyotrophic lateral sclerosis | 98/684 | 364/8465 | 2.13e-28 | 8.41e-27 | 6.44e-27 | 98 |
hsa0502217 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0520819 | Breast | Precancer | Chemical carcinogenesis - reactive oxygen species | 68/684 | 223/8465 | 3.61e-23 | 1.14e-21 | 8.73e-22 | 68 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NDUFV3 | SNV | Missense_Mutation | rs775969714 | c.731N>A | p.Arg244Lys | p.R244K | P56181 | protein_coding | tolerated(1) | benign(0.006) | TCGA-BH-A0HB-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | docetaxel | SD |
NDUFV3 | SNV | Missense_Mutation | c.758A>G | p.Gln253Arg | p.Q253R | P56181 | protein_coding | tolerated(0.16) | benign(0.221) | TCGA-D8-A1XK-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicine+cyclophosphamide | SD | |
NDUFV3 | SNV | Missense_Mutation | c.481N>A | p.Asp161Asn | p.D161N | P56181 | protein_coding | deleterious(0.03) | probably_damaging(0.996) | TCGA-E9-A243-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | PD | |
NDUFV3 | SNV | Missense_Mutation | c.1114N>A | p.Glu372Lys | p.E372K | P56181 | protein_coding | deleterious(0.01) | probably_damaging(0.952) | TCGA-AA-3492-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
NDUFV3 | SNV | Missense_Mutation | c.533N>A | p.Val178Glu | p.V178E | P56181 | protein_coding | tolerated(0.15) | benign(0.283) | TCGA-AD-6889-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | xeloda | PD | |
NDUFV3 | SNV | Missense_Mutation | rs373783778 | c.599N>A | p.Arg200Gln | p.R200Q | P56181 | protein_coding | tolerated(0.41) | benign(0) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NDUFV3 | SNV | Missense_Mutation | novel | c.383N>G | p.Val128Gly | p.V128G | P56181 | protein_coding | deleterious(0) | possibly_damaging(0.881) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
NDUFV3 | SNV | Missense_Mutation | rs373783778 | c.599N>A | p.Arg200Gln | p.R200Q | P56181 | protein_coding | tolerated(0.41) | benign(0) | TCGA-F4-6463-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NDUFV3 | SNV | Missense_Mutation | novel | c.810A>C | p.Lys270Asn | p.K270N | P56181 | protein_coding | tolerated(0.2) | benign(0.022) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NDUFV3 | SNV | Missense_Mutation | c.476N>A | p.Ser159Tyr | p.S159Y | P56181 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-A5-A0G1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
4731 | NDUFV3 | ENZYME | inhibitor | CHEMBL1703 | METFORMIN HYDROCHLORIDE | |
4731 | NDUFV3 | ENZYME | inhibitor | CHEMBL3545135 | NV-128 | |
4731 | NDUFV3 | ENZYME | inhibitor | CHEMBL3545320 | ME-344 |
Page: 1 |